• No results found

Phylogenetic placement and characterization of a new alpha 2 proteobacterium isolated from a patient with sepsis

N/A
N/A
Protected

Academic year: 2020

Share "Phylogenetic placement and characterization of a new alpha 2 proteobacterium isolated from a patient with sepsis"

Copied!
8
0
0

Loading.... (view fulltext now)

Full text

Figure

FIG. 1. Evolutionary distance tree of representatives of the alpha subclass of the Proteobacteriaas an outgroup
TABLE 1. Similarity matrix based on 16S rDNA sequence comparisons
FIG. 2. Transmission electron microscopy of isolated bacteria showing onepolar flagellum in negative staining (a) and electron-dense formations within the
TABLE 2. Comparison of the biochemical activities of the isolatedorganism and B. henselae and A
+2

References

Related documents

The project involved a review of current uses of digital print on knitwear both internationally and in New Zealand; the development of a range of digitally printed

In the study presented here, we selected three rep- resentative pathogenic PV mAbs cloned from 3 different PV patients: F706, an anti-Dsg3 IgG4 isolated by heterohybridoma, F779,

As inter-speaker variability among these the two groups was minimal, ranging from 0% to 2% of lack of concord in the 21-40 group and from 41% to 46% in the 71+ generation, we

For the poorest farmers in eastern India, then, the benefits of groundwater irrigation have come through three routes: in large part, through purchased pump irrigation and, in a

Specification requirements vary with the proposed end-use; hence rock crushed for use as sealing aggregate is required to meet more stringent test criteria than that accepted as

Search term: ((teacher OR teachers OR staff OR school) WITHIN 5 (attendance OR presence OR absence OR absenteeism OR truancy OR shirking)) AND (intervention OR program OR programme OR

The results were sensitive to: the remission rates maintained in responders to 'usual care' and to 5 mg/kg infliximab, the rate of remission induced by adalimumab in non-responders to

Intervention effects with respect to ‘ PTA ’ , ‘ INFO ’ , ‘ SAFED ’ , clinical patient outcomes, and health-related quality of life were estimated using general- ised